Pemetrexed is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Qilu Pharmaceutical Co., Ltd.. The primary component is Pemetrexed Disodium Hemipentahydrate.
Product ID | 67184-0504_0dc735ab-c4c9-4e19-bb80-8a439be7208c |
NDC | 67184-0504 |
Product Type | Human Prescription Drug |
Proprietary Name | Pemetrexed |
Generic Name | Pemetrexed Disodium |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2022-05-25 |
Marketing Category | ANDA / |
Application Number | ANDA204890 |
Labeler Name | Qilu Pharmaceutical Co., Ltd. |
Substance Name | PEMETREXED DISODIUM HEMIPENTAHYDRATE |
Active Ingredient Strength | 500 mg/20mL |
Pharm Classes | Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-05-25 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | export only |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2018-09-11 |
Inactivation Date | 2020-01-31 |
NDC | Brand Name | Generic Name |
---|---|---|
0338-0720 | PEMETREXED | PEMETREXED |
0338-0722 | PEMETREXED | PEMETREXED |
0409-1045 | PEMETREXED | PEMETREXED |
0409-1060 | Pemetrexed | Pemetrexed |
0409-1061 | Pemetrexed | Pemetrexed |
0409-1062 | Pemetrexed | Pemetrexed |
0409-2188 | PEMETREXED | PEMETREXED |
0409-3532 | PEMETREXED | PEMETREXED |
0480-4514 | Pemetrexed | Pemetrexed |
0480-4515 | Pemetrexed | Pemetrexed |
0480-4516 | Pemetrexed | Pemetrexed |
0781-3518 | Pemetrexed | Pemetrexed disodium |
0781-3519 | Pemetrexed | Pemetrexed disodium |
0781-3520 | Pemetrexed | Pemetrexed disodium |
16729-229 | Pemetrexed | Pemetrexed |
16729-230 | Pemetrexed | Pemetrexed |
16729-244 | Pemetrexed | Pemetrexed |
16729-522 | Pemetrexed | Pemetrexed disodium |
0002-7623 | Alimta | Pemetrexed disodium |
0002-7640 | Alimta | Pemetrexed disodium |